synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxyglucose …

[18F]fluoromethyl-2-hydroxyethylammonium (FCH]) and 18F-fluoro-2-deoxyglucose (FDG) ..

FDG - 2-[(18)F]fluoro-2-deoxy-D-glucose | AcronymAttic

Dynamic positron-emission tomography (PET) imaging of the radiotracer 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) is increasingly used to assess metabolic activity of lung inflammatory cells. To analyze the kinetics of 18F-FDG in brain and tumor tissues the ‘Sokoloff’ model has been typically used. In the lungs, however, a high blood-to-parenchymal volume ratio and 18F-FDG distribution in edematous injured tissue could require a modified model to properly describe 18F-FDG kinetics.

to compare the cisplatin sensitivity and 18F fluoro-2 deoxy 2 glucose (18F-FDG) ..

[18F]FDG (2-[18F]Fluoro-2-deoxy-d ..

9. Moroz MA, Kochetkov T, Cai S, Wu J, Shamis M, Nair J. . Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imaging. 2011Mar;17(5):1099-110

The aim of this study was to establish and characterize a series of cell lines and to compare the cisplatin sensitivity and 18F fluoro-2 deoxy 2 glucose (18F-FDG) uptake of these cell lines with other cellular characteristics, such as proliferation parameters and TP53 and CCND1 status.